speb/financial-data huggingface dataset:
RNAC income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 4354000.00
RNAC income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 23100000.00
RNAC balance_sheet (annual, 2025-12-31) — Retained Earnings: -822373000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -822373000.00
RNAC cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
RNAC income_statement (annual, 2025-12-31) — Selling General And Administration: 31468000.00
RNAC income_statement (quarterly, 2025-12-31) — Selling General And Administration: 8197000.00
RNAC balance_sheet (annual, 2025-12-31) — Share Issued: 26011106.00
RNAC balance_sheet (quarterly, 2025-12-31) — Share Issued: 26011106.00
RNAC income_statement (annual, 2025-12-31) — Special Income Charges: -61054000.00
RNAC income_statement (quarterly, 2025-12-31) — Special Income Charges: -79800000.00
RNAC cash_flow (annual, 2025-12-31) — Stock Based Compensation: 10521000.00
RNAC cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2144000.00
RNAC balance_sheet (annual, 2025-12-31) — Stockholders Equity: -126240000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -126240000.00
RNAC balance_sheet (annual, 2025-12-31) — Tangible Book Value: -268303000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -268303000.00
RNAC income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3785694.00
RNAC income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
RNAC income_statement (annual, 2025-12-31) — Tax Provision: -9193000.00
RNAC income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.07
RNAC income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
RNAC balance_sheet (annual, 2025-12-31) — Total Assets: 296411000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Total Assets: 296411000.00
RNAC balance_sheet (annual, 2025-12-31) — Total Capitalization: -126240000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -126240000.00
RNAC balance_sheet (annual, 2025-12-31) — Total Debt: 12676000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Total Debt: 12676000.00
RNAC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -126240000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -126240000.00
RNAC income_statement (annual, 2025-12-31) — Total Expenses: 89502000.00
RNAC income_statement (quarterly, 2025-12-31) — Total Expenses: 22886000.00
RNAC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 422651000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 422651000.00
RNAC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 167135000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 167135000.00
RNAC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 407714000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 407714000.00
RNAC income_statement (annual, 2025-12-31) — Total Unusual Items: -57359000.00
RNAC income_statement (quarterly, 2025-12-31) — Total Unusual Items: -79093000.00
RNAC income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -57359000.00
RNAC income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -79093000.00
RNAC balance_sheet (annual, 2025-12-31) — Working Capital: 114339000.00
RNAC balance_sheet (quarterly, 2025-12-31) — Working Capital: 114339000.00
RNAC income_statement (quarterly, 2026-03-31) — +Operating Expense: 26577000.00
RNAC income_statement (quarterly, 2026-03-31) — +Total Revenue: 78000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1598000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 261000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -5348000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 718017000.00
RNAC income_statement (quarterly, 2026-03-31) — Basic Average Shares: 26855158.00
RNAC income_statement (quarterly, 2026-03-31) — Basic EPS: -1.46
RNAC cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 126874000.00
RNAC cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -27000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 11855000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 118641000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 118641000.00
RNAC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 15671000.00
RNAC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -27000.00
RNAC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -22135000.00
RNAC cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 310000.00
RNAC cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -850000.00
RNAC cash_flow (quarterly, 2026-03-31) — Change In Payable: 310000.00
RNAC cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -540000.00
RNAC cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -246000.00
RNAC cash_flow (quarterly, 2026-03-31) — Change In Receivables: 854000.00
RNAC cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 68000.00
RNAC cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 854000.00
RNAC cash_flow (quarterly, 2026-03-31) — Changes In Cash: -6491000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Common Stock: 3000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -148118000.00
RNAC cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 15392000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 59000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 10161000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Current Assets: 122039000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 4186000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4186000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 15945000.00
RNAC cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 615000.00
RNAC cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 615000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 47000.00
RNAC income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 26855158.00
RNAC income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.46
RNAC income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -39182000.00
RNAC income_statement (quarterly, 2026-03-31) — EBIT: -26499000.00
RNAC income_statement (quarterly, 2026-03-31) — EBITDA: -25884000.00
RNAC cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -7000.00
RNAC cash_flow (quarterly, 2026-03-31) — End Cash Position: 120376000.00
RNAC cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 15671000.00
RNAC cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -22162000.00
RNAC cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -94000.00
RNAC income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 1120000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -4583000.00
RNAC income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 7114000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Goodwill: 48163000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 142063000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Gross PPE: 22351000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Invested Capital: -148118000.00
RNAC cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -27000.00
RNAC cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 15392000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Leases: 6709000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 7669000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7669000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 894000.00
RNAC cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 15392000.00
RNAC income_statement (quarterly, 2026-03-31) — Net Income: -39182000.00
RNAC income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -39182000.00
RNAC income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -39182000.00
RNAC income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -39182000.00
RNAC income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -39182000.00
RNAC cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -39182000.00
RNAC income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -39182000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Net PPE: 17003000.00
RNAC cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -27000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -290181000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 6948000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 6948000.00
RNAC income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -13204000.00
RNAC income_statement (quarterly, 2026-03-31) — Normalized Income: -26502000.00
RNAC cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -22135000.00
RNAC cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -94000.00
RNAC income_statement (quarterly, 2026-03-31) — Operating Income: -26499000.00
RNAC income_statement (quarterly, 2026-03-31) — Operating Revenue: 78000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 28544728.00
RNAC balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3137000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -4583000.00
RNAC income_statement (quarterly, 2026-03-31) — Other Gand A: 7114000.00
RNAC income_statement (quarterly, 2026-03-31) — Other Income Expense: -12683000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 93900000.00
RNAC cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 14035000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 7286000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 405900000.00
RNAC income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -3000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Other Properties: 14689000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Payables: 1598000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 11759000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
RNAC income_statement (quarterly, 2026-03-31) — Pretax Income: -39182000.00
RNAC cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 279000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
RNAC cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -27000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Receivables: 261000.00
RNAC income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 615000.00
RNAC income_statement (quarterly, 2026-03-31) — Research And Development: 19463000.00
RNAC income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 13800000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -861555000.00
RNAC income_statement (quarterly, 2026-03-31) — Selling General And Administration: 7114000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Share Issued: 28544728.00
RNAC income_statement (quarterly, 2026-03-31) — Special Income Charges: -13800000.00
RNAC cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2423000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -148118000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -290181000.00
RNAC income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
RNAC income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
RNAC balance_sheet (quarterly, 2026-03-31) — Total Assets: 288391000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -148118000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Total Debt: 11855000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -148118000.00
RNAC income_statement (quarterly, 2026-03-31) — Total Expenses: 26577000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 436509000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 166352000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 420564000.00
RNAC income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -26499000.00
RNAC income_statement (quarterly, 2026-03-31) — Total Unusual Items: -12680000.00
RNAC income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -12680000.00
RNAC balance_sheet (quarterly, 2026-03-31) — Working Capital: 106094000.00
RNAZ cash_flow (annual, 2021-12-31) — Change In Account Payable: 2285059.00
RNAZ cash_flow (annual, 2021-12-31) — Change In Accrued Expense: 55598.00
RNAZ cash_flow (annual, 2021-12-31) — Change In Interest Payable: 55598.00
RNAZ cash_flow (annual, 2021-12-31) — Change In Payable: 2285059.00
RNAZ balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 0.00
RNAZ balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 0.00
RNAZ cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 873109.00
RNAZ cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 3082.00
RNAZ income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -873109.00
RNAZ cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 0.00
RNAZ cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
RNAZ cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
RNAZ cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
RNAZ cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
RNAZ cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -847818.00
RNAZ balance_sheet (annual, 2021-12-31) — Non Current Accrued Expenses: 0.00
RNAZ balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 0.00
RNAZ cash_flow (annual, 2021-12-31) — Operating Gains Losses: 876191.00
RNAZ income_statement (annual, 2021-12-31) — Other Income Expense: -876191.00
RNAZ cash_flow (annual, 2021-12-31) — Other Non Cash Items: 3786.00
RNAZ balance_sheet (annual, 2021-12-31) — Other Properties: 247522.00
RNAZ cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 29267.00
RNAZ cash_flow (annual, 2021-12-31) — Sale Of PPE: 3000.00
RNAZ income_statement (annual, 2022-12-31) — +Operating Expense: 17553392.00
RNAZ income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -139860.00
RNAZ balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 31110943.00
RNAZ income_statement (annual, 2022-12-31) — Basic Average Shares: 17.00
RNAZ income_statement (annual, 2022-12-31) — Basic EPS: -1033233.41
RNAZ cash_flow (annual, 2022-12-31) — Beginning Cash Position: 20825860.00
RNAZ cash_flow (annual, 2022-12-31) — Capital Expenditure: -100919.00
RNAZ balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Capital Stock: 2.00
RNAZ balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4968418.00
RNAZ balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 4968418.00
RNAZ balance_sheet (annual, 2022-12-31) — Cash Financial: 4968418.00
RNAZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 5989.00
RNAZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -100919.00
RNAZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -15762512.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Account Payable: 1843722.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 0.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Interest Payable: 0.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 0.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 0.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -30528.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Payable: 1843722.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1843722.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -144444.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Receivables: -360229.00
RNAZ cash_flow (annual, 2022-12-31) — Change In Working Capital: 1308521.00
RNAZ cash_flow (annual, 2022-12-31) — Changes In Cash: -15857442.00
RNAZ balance_sheet (annual, 2022-12-31) — Common Stock: 2.00
RNAZ balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3240696.00
RNAZ cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 4347290.00
RNAZ balance_sheet (annual, 2022-12-31) — Current Assets: 7379405.00
RNAZ balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Current Liabilities: 4347290.00
RNAZ cash_flow (annual, 2022-12-31) — Depreciation: 98606.00
RNAZ cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 98606.00
RNAZ cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 98606.00
RNAZ income_statement (annual, 2022-12-31) — Diluted Average Shares: 17.00
RNAZ income_statement (annual, 2022-12-31) — Diluted EPS: -1033233.41
RNAZ income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -17564968.00
RNAZ income_statement (annual, 2022-12-31) — EBIT: -17532982.00
RNAZ income_statement (annual, 2022-12-31) — EBITDA: -17434376.00
RNAZ cash_flow (annual, 2022-12-31) — End Cash Position: 4968418.00
RNAZ cash_flow (annual, 2022-12-31) — Financing Cash Flow: 5989.00
RNAZ cash_flow (annual, 2022-12-31) — Free Cash Flow: -15863431.00
RNAZ cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
RNAZ income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00
RNAZ income_statement (annual, 2022-12-31) — General And Administrative Expense: 8401462.00
RNAZ balance_sheet (annual, 2022-12-31) — Gross PPE: 348441.00
RNAZ income_statement (annual, 2022-12-31) — Interest Expense: 31986.00
RNAZ income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 31986.00
RNAZ income_statement (annual, 2022-12-31) — Interest Income: 20410.00
RNAZ income_statement (annual, 2022-12-31) — Interest Income Non Operating: 20410.00
RNAZ cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 37115.00
RNAZ balance_sheet (annual, 2022-12-31) — Invested Capital: 3240696.00
RNAZ cash_flow (annual, 2022-12-31) — Investing Cash Flow: -100919.00
RNAZ cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 348441.00
RNAZ cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
RNAZ income_statement (annual, 2022-12-31) — Net Income: -17564968.00
RNAZ income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -17564968.00
RNAZ income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -17564968.00
RNAZ income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -17564968.00
RNAZ income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -17564968.00
RNAZ cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -17564968.00
RNAZ income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -17564968.00
RNAZ income_statement (annual, 2022-12-31) — Net Interest Income: -11576.00
RNAZ income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -11576.00
RNAZ balance_sheet (annual, 2022-12-31) — Net PPE: 208581.00
RNAZ cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -100919.00
RNAZ balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3240696.00
RNAZ balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 0.00
RNAZ income_statement (annual, 2022-12-31) — Normalized EBITDA: -17434376.00
RNAZ income_statement (annual, 2022-12-31) — Normalized Income: -17564968.00
RNAZ cash_flow (annual, 2022-12-31) — Operating Cash Flow: -15762512.00
RNAZ income_statement (annual, 2022-12-31) — Operating Income: -17553392.00
RNAZ income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 17.00
RNAZ balance_sheet (annual, 2022-12-31) — Other Current Assets: 1496428.00
RNAZ income_statement (annual, 2022-12-31) — Other Gand A: 8401462.00
RNAZ income_statement (annual, 2022-12-31) — Other Operating Expenses: -1080436.00
RNAZ balance_sheet (annual, 2022-12-31) — Other Receivables: 360229.00
RNAZ balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4347290.00
RNAZ balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Prepaid Assets: 554330.00
RNAZ income_statement (annual, 2022-12-31) — Pretax Income: -17564968.00
RNAZ cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 5989.00
RNAZ cash_flow (annual, 2022-12-31) — Purchase Of PPE: -100919.00
RNAZ balance_sheet (annual, 2022-12-31) — Receivables: 360229.00
RNAZ income_statement (annual, 2022-12-31) — Reconciled Depreciation: 98606.00
RNAZ income_statement (annual, 2022-12-31) — Research And Development: 10232366.00
RNAZ balance_sheet (annual, 2022-12-31) — Retained Earnings: -27870249.00
RNAZ cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
RNAZ income_statement (annual, 2022-12-31) — Selling General And Administration: 8401462.00
RNAZ balance_sheet (annual, 2022-12-31) — Share Issued: 17.00
RNAZ income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
RNAZ cash_flow (annual, 2022-12-31) — Stock Based Compensation: 395329.00
RNAZ balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3240696.00
RNAZ balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3240696.00
RNAZ income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
RNAZ income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Total Assets: 7587986.00
RNAZ balance_sheet (annual, 2022-12-31) — Total Capitalization: 3240696.00
RNAZ balance_sheet (annual, 2022-12-31) — Total Debt: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3240696.00
RNAZ income_statement (annual, 2022-12-31) — Total Expenses: 17553392.00
RNAZ balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4347290.00
RNAZ balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 208581.00
RNAZ balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
RNAZ income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -18633828.00
RNAZ income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
RNAZ income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
RNAZ balance_sheet (annual, 2022-12-31) — Working Capital: 3032115.00
RNAZ income_statement (annual, 2023-12-31) — +Operating Expense: 18495481.00
RNAZ income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
RNAZ balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -263343.00
RNAZ balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 48057156.00
RNAZ income_statement (annual, 2023-12-31) — Basic Average Shares: 679.00
RNAZ income_statement (annual, 2023-12-31) — Basic EPS: -27313.84
RNAZ cash_flow (annual, 2023-12-31) — Beginning Cash Position: 4968418.00
RNAZ cash_flow (annual, 2023-12-31) — Capital Expenditure: -35609.00
RNAZ balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 450571.00
RNAZ balance_sheet (annual, 2023-12-31) — Capital Stock: 2.00
RNAZ balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2767598.00
RNAZ balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 2767598.00
RNAZ balance_sheet (annual, 2023-12-31) — Cash Financial: 2767598.00
RNAZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 15909324.00
RNAZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -35609.00
RNAZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -18074535.00
RNAZ cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -111856.00
RNAZ cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -424385.00
RNAZ cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 27057.00
RNAZ cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -1296032.00
RNAZ cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 362912.00
RNAZ cash_flow (annual, 2023-12-31) — Change In Receivables: 360229.00
RNAZ cash_flow (annual, 2023-12-31) — Change In Working Capital: -1082075.00
RNAZ cash_flow (annual, 2023-12-31) — Changes In Cash: -2200820.00
RNAZ balance_sheet (annual, 2023-12-31) — Common Stock: 2.00
RNAZ balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1640814.00
RNAZ cash_flow (annual, 2023-12-31) — Common Stock Issuance: 15909324.00
RNAZ balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 3051259.00
RNAZ balance_sheet (annual, 2023-12-31) — Current Assets: 4455444.00
RNAZ balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 412280.00
RNAZ balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 412280.00
RNAZ balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 27057.00
RNAZ balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 27057.00
RNAZ balance_sheet (annual, 2023-12-31) — Current Liabilities: 3490596.00
RNAZ cash_flow (annual, 2023-12-31) — Depreciation: 516746.00
RNAZ cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 516746.00
RNAZ cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 516746.00
RNAZ balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 0.00
RNAZ income_statement (annual, 2023-12-31) — Diluted Average Shares: 679.00
RNAZ income_statement (annual, 2023-12-31) — Diluted EPS: -27313.84
RNAZ income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -18546095.00
RNAZ income_statement (annual, 2023-12-31) — EBIT: -18490196.00
RNAZ income_statement (annual, 2023-12-31) — EBITDA: -17973450.00
RNAZ cash_flow (annual, 2023-12-31) — End Cash Position: 2767598.00
RNAZ cash_flow (annual, 2023-12-31) — Financing Cash Flow: 15909324.00
RNAZ cash_flow (annual, 2023-12-31) — Free Cash Flow: -18110144.00
RNAZ income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
RNAZ income_statement (annual, 2023-12-31) — General And Administrative Expense: 7154986.00
RNAZ balance_sheet (annual, 2023-12-31) — Gross PPE: 865744.00
RNAZ income_statement (annual, 2023-12-31) — Interest Expense: 55899.00
RNAZ income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 55899.00
RNAZ income_statement (annual, 2023-12-31) — Interest Income: 5285.00
RNAZ income_statement (annual, 2023-12-31) — Interest Income Non Operating: 5285.00
RNAZ cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 32861.00
RNAZ balance_sheet (annual, 2023-12-31) — Invested Capital: 1640814.00
RNAZ cash_flow (annual, 2023-12-31) — Investing Cash Flow: -35609.00
RNAZ cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 15909324.00
RNAZ balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 38291.00
RNAZ balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 38291.00
RNAZ balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 384050.00
RNAZ cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 15909324.00
RNAZ income_statement (annual, 2023-12-31) — Net Income: -18546095.00
RNAZ income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -18546095.00
RNAZ income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -18546095.00
RNAZ income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -18546095.00
RNAZ income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -18546095.00
RNAZ cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -18546095.00
RNAZ income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -18546095.00
RNAZ income_statement (annual, 2023-12-31) — Net Interest Income: -50614.00
RNAZ income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -50614.00
RNAZ balance_sheet (annual, 2023-12-31) — Net PPE: 602401.00
RNAZ cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -35609.00
RNAZ balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1640814.00
RNAZ balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 111856.00
RNAZ income_statement (annual, 2023-12-31) — Normalized EBITDA: -17973450.00
RNAZ income_statement (annual, 2023-12-31) — Normalized Income: -18546095.00
RNAZ cash_flow (annual, 2023-12-31) — Operating Cash Flow: -18074535.00
RNAZ income_statement (annual, 2023-12-31) — Operating Income: -18495481.00
RNAZ income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
RNAZ balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 679.00
RNAZ balance_sheet (annual, 2023-12-31) — Other Current Assets: 1148747.00
RNAZ income_statement (annual, 2023-12-31) — Other Gand A: 7154986.00
RNAZ income_statement (annual, 2023-12-31) — Other Operating Expenses: -923035.00
RNAZ balance_sheet (annual, 2023-12-31) — Other Properties: 481694.00
RNAZ income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
RNAZ balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 3051259.00
RNAZ balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
RNAZ balance_sheet (annual, 2023-12-31) — Prepaid Assets: 539099.00
RNAZ income_statement (annual, 2023-12-31) — Pretax Income: -18546095.00
RNAZ cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
RNAZ cash_flow (annual, 2023-12-31) — Purchase Of PPE: -35609.00
RNAZ balance_sheet (annual, 2023-12-31) — Receivables: 0.00
RNAZ income_statement (annual, 2023-12-31) — Reconciled Depreciation: 516746.00
RNAZ income_statement (annual, 2023-12-31) — Research And Development: 12263530.00
RNAZ balance_sheet (annual, 2023-12-31) — Retained Earnings: -46416344.00
RNAZ income_statement (annual, 2023-12-31) — Selling General And Administration: 7154986.00
RNAZ balance_sheet (annual, 2023-12-31) — Share Issued: 679.00
RNAZ income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
RNAZ cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1036889.00
RNAZ balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1640814.00
RNAZ balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1640814.00
RNAZ income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
RNAZ income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
RNAZ balance_sheet (annual, 2023-12-31) — Total Assets: 5169701.00
RNAZ balance_sheet (annual, 2023-12-31) — Total Capitalization: 1640814.00
RNAZ balance_sheet (annual, 2023-12-31) — Total Debt: 450571.00
RNAZ balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1640814.00
RNAZ income_statement (annual, 2023-12-31) — Total Expenses: 18495481.00
RNAZ balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3528887.00
RNAZ balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 714257.00
RNAZ balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 38291.00
RNAZ income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -19418516.00
RNAZ income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
RNAZ income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
RNAZ balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
RNAZ balance_sheet (annual, 2023-12-31) — Working Capital: 964848.00
RNAZ income_statement (quarterly, 2024-09-30) — Basic Average Shares: 15893.00
RNAZ income_statement (quarterly, 2024-09-30) — Basic EPS: -146.06
RNAZ cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -12870.00
RNAZ cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: 0.00
RNAZ balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 152481.00
RNAZ income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 15893.00
RNAZ income_statement (quarterly, 2024-09-30) — Diluted EPS: -146.06
RNAZ balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 0.00
RNAZ balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 0.00
RNAZ balance_sheet (quarterly, 2024-09-30) — Other Properties: 150240.00
RNAZ balance_sheet (quarterly, 2024-09-30) — Other Receivables: 11953.00
RNAZ income_statement (annual, 2024-12-31) — +Operating Expense: 15136633.00
RNAZ income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -310813.00
RNAZ balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 61183178.00
RNAZ income_statement (annual, 2024-12-31) — Basic Average Shares: 12558.00
RNAZ income_statement (annual, 2024-12-31) — Basic EPS: -1336.63
RNAZ cash_flow (annual, 2024-12-31) — Beginning Cash Position: 2767598.00
RNAZ cash_flow (annual, 2024-12-31) — Capital Expenditure: -21761.00
RNAZ cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -500.00
RNAZ balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 38291.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 38291.00
RNAZ balance_sheet (annual, 2024-12-31) — Capital Stock: 4.00
RNAZ balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 5811064.00
RNAZ balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5811064.00
RNAZ balance_sheet (annual, 2024-12-31) — Cash Financial: 5811064.00
RNAZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 16401174.00
RNAZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -21761.00
RNAZ cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -500.00
RNAZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -13335947.00
RNAZ cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 0.00
RNAZ cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 0.00
RNAZ cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -412280.00
RNAZ cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -1649.00
RNAZ cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -343123.00
RNAZ cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 405573.00
RNAZ cash_flow (annual, 2024-12-31) — Change In Receivables: 0.00
RNAZ cash_flow (annual, 2024-12-31) — Change In Working Capital: -351479.00
RNAZ cash_flow (annual, 2024-12-31) — Changes In Cash: 3043466.00
RNAZ balance_sheet (annual, 2024-12-31) — Common Stock: 4.00
RNAZ balance_sheet (annual, 2024-12-31) — Common Stock Equity: -2018734.00
RNAZ cash_flow (annual, 2024-12-31) — Common Stock Issuance: 16401174.00
RNAZ balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2708137.00
RNAZ balance_sheet (annual, 2024-12-31) — Current Assets: 7093338.00
RNAZ balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 38291.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 38291.00
RNAZ balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 38291.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 38291.00
RNAZ balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 25408.00
RNAZ balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 25408.00
RNAZ balance_sheet (annual, 2024-12-31) — Current Liabilities: 2771836.00
RNAZ cash_flow (annual, 2024-12-31) — Depreciation: 534857.00
RNAZ cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 534857.00
RNAZ cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 534857.00
RNAZ balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 6541397.00
RNAZ income_statement (annual, 2024-12-31) — Diluted Average Shares: 12558.00
RNAZ income_statement (annual, 2024-12-31) — Diluted EPS: -1336.63
RNAZ income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -16785572.00
RNAZ balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 0.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 0.00
RNAZ income_statement (annual, 2024-12-31) — EBIT: -16728158.00
RNAZ income_statement (annual, 2024-12-31) — EBITDA: -16193301.00
RNAZ cash_flow (annual, 2024-12-31) — End Cash Position: 5811064.00
RNAZ cash_flow (annual, 2024-12-31) — Financing Cash Flow: 16401174.00
RNAZ cash_flow (annual, 2024-12-31) — Free Cash Flow: -13357708.00
RNAZ cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 1535647.00
RNAZ income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 500.00
RNAZ income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -995752.00
RNAZ income_statement (annual, 2024-12-31) — General And Administrative Expense: 5954339.00
RNAZ balance_sheet (annual, 2024-12-31) — Goodwill: 0.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Goodwill: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Gross PPE: 400118.00
RNAZ income_statement (annual, 2024-12-31) — Interest Expense: 26813.00
RNAZ income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 26813.00
RNAZ income_statement (annual, 2024-12-31) — Interest Income: 684.00
RNAZ income_statement (annual, 2024-12-31) — Interest Income Non Operating: 684.00
RNAZ cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 16629.00
RNAZ cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Invested Capital: -2018734.00
RNAZ cash_flow (annual, 2024-12-31) — Investing Cash Flow: -21761.00
RNAZ cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -500.00
RNAZ cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 16401174.00
RNAZ balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 362387.00
RNAZ cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
RNAZ cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 16401174.00
RNAZ income_statement (annual, 2024-12-31) — Net Income: -16754971.00
RNAZ income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -16785572.00
RNAZ income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -16754971.00
RNAZ income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -16754971.00
RNAZ income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -16754971.00
RNAZ cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -16754971.00
RNAZ income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -16754971.00
RNAZ income_statement (annual, 2024-12-31) — Net Interest Income: -623086.00
RNAZ income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -623086.00
RNAZ balance_sheet (annual, 2024-12-31) — Net PPE: 89305.00
RNAZ cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -21761.00
RNAZ cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -500.00
RNAZ cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -2018734.00
RNAZ balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 111856.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 111856.00
RNAZ income_statement (annual, 2024-12-31) — Normalized EBITDA: -15198049.00
RNAZ income_statement (annual, 2024-12-31) — Normalized Income: -15759719.00
RNAZ cash_flow (annual, 2024-12-31) — Operating Cash Flow: -13335947.00
RNAZ cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1535647.00
RNAZ income_statement (annual, 2024-12-31) — Operating Income: -15136633.00
RNAZ income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 36753.00
RNAZ balance_sheet (annual, 2024-12-31) — Other Current Assets: 828219.00
RNAZ income_statement (annual, 2024-12-31) — Other Gand A: 5954339.00
RNAZ income_statement (annual, 2024-12-31) — Other Income Expense: -995252.00
RNAZ income_statement (annual, 2024-12-31) — Other Operating Expenses: -524064.00
RNAZ balance_sheet (annual, 2024-12-31) — Other Properties: 37731.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Other Properties: 37731.00
RNAZ income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 30601.00
RNAZ balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2708137.00
RNAZ balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
RNAZ cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Prepaid Assets: 454055.00
RNAZ income_statement (annual, 2024-12-31) — Pretax Income: -16754971.00
RNAZ cash_flow (annual, 2024-12-31) — Purchase Of PPE: -21761.00
RNAZ cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -500.00
RNAZ balance_sheet (annual, 2024-12-31) — Receivables: 0.00
RNAZ income_statement (annual, 2024-12-31) — Reconciled Depreciation: 534857.00
RNAZ income_statement (annual, 2024-12-31) — Research And Development: 9706358.00
RNAZ income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Retained Earnings: -63201916.00
RNAZ cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
RNAZ income_statement (annual, 2024-12-31) — Selling General And Administration: 5954339.00
RNAZ balance_sheet (annual, 2024-12-31) — Share Issued: 36753.00
RNAZ income_statement (annual, 2024-12-31) — Special Income Charges: 500.00
RNAZ cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1699999.00
RNAZ balance_sheet (annual, 2024-12-31) — Stockholders Equity: -2018734.00
RNAZ balance_sheet (annual, 2024-12-31) — Tangible Book Value: -2018734.00
RNAZ income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
RNAZ income_statement (annual, 2024-12-31) — Tax Provision: 0.00
RNAZ income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
RNAZ balance_sheet (annual, 2024-12-31) — Total Assets: 7294499.00
RNAZ balance_sheet (annual, 2024-12-31) — Total Capitalization: -2018734.00
RNAZ balance_sheet (annual, 2024-12-31) — Total Debt: 38291.00
RNAZ balance_sheet (quarterly, 2024-12-31) — Total Debt: 38291.00
RNAZ balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -2018734.00
RNAZ income_statement (annual, 2024-12-31) — Total Expenses: 15136633.00
RNAZ balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 9313233.00
RNAZ balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 201161.00
RNAZ balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 6541397.00
RNAZ income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -15660697.00
RNAZ income_statement (annual, 2024-12-31) — Total Other Finance Cost: 596957.00
RNAZ income_statement (annual, 2024-12-31) — Total Unusual Items: -995252.00
RNAZ income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -995252.00
RNAZ balance_sheet (annual, 2024-12-31) — Working Capital: 4321502.00
RNAZ income_statement (quarterly, 2025-03-31) — +Operating Expense: 2823335.00
RNAZ income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -324256.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 85577693.00
RNAZ income_statement (quarterly, 2025-03-31) — Basic Average Shares: 172262.00
RNAZ income_statement (quarterly, 2025-03-31) — Basic EPS: -70.16
RNAZ cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 5811064.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2334.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 11569154.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 11569154.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Cash Financial: 11569154.00
RNAZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 8854797.00
RNAZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
RNAZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3096707.00
RNAZ cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -38291.00
RNAZ cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -25408.00
RNAZ cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -198459.00
RNAZ cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 129475.00
RNAZ cash_flow (quarterly, 2025-03-31) — Change In Receivables: -322436.00
RNAZ cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -455119.00
RNAZ cash_flow (quarterly, 2025-03-31) — Changes In Cash: 5758090.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Common Stock: 2334.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 10292698.00
RNAZ cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 8854797.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2509677.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Current Assets: 13044388.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2509677.00
RNAZ cash_flow (quarterly, 2025-03-31) — Depreciation: 51174.00
RNAZ cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 51174.00